Global Brain Tumor Therapeutics Market 2019-2023 | 12% CAGR Projection Over the Next Five Years | Technavio

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global brain tumor therapeutics market is expected to post a CAGR of
close to 12% during the period 2019-2023, according to the latest market
research report by Technavio.

A key factor driving the growth of the global brain tumor therapeutics
market is the high morbidity of brain tumors. Although most brain tumors
are benign in nature, the morbidity of these tumors is very high, as
they manifest the symptoms of a malignant tumor. If not removed on time,
these tumors can become life-threatening and can significantly affect
the quality of life of the patient. The morbid nature of malignant
tumors has created a huge unmet need in the market. As a result, vendors
are conducting heavy research on developing novel therapies that are a
combination of either vaccines or CAR T-cells with various checkpoint
inhibitors. Thus, the high morbidity of brain tumors will drive the
growth of the brain tumor therapeutics market during the forecast period.

As per Technavio, the advent of novel therapies will have a positive
impact on the market and contribute to its growth significantly over the
forecast period. This global
brain tumor therapeutics market 2019-2023
research report also analyzes other important trends and
market drivers that will affect market growth over 2019-2023.

Global brain tumor therapeutics market: Advent
of novel therapies

The brain tumor therapeutics market is witnessing the emergence of novel
therapies with constant efforts from researchers on advanced therapies
for the treatment of the indication. Brain cancer is one of the most
heavily researched cancer types in most of the developed countries, and
the pipeline for brain cancer treatment is growing significantly. A
significant number of drugs are expected to receive marketing approval
during the second half of the forecast period. The high efficacy of
novel drugs will result in increased demand, thereby adding significant
value to the growth of the global brain tumor therapeutics market.

“Apart from the advent of novel therapies, factors such as growing
awareness campaigns, special drug designations, and the increasing
prevalence of brain cancer will have a significant impact on the growth
of the brain tumor therapeutics market during the forecast period,” says
a senior research analyst at Technavio.

Global brain tumor therapeutics market:
Segmentation analysis

This market research report segments the global brain tumor therapeutics
market by type (small molecules, and biologics) and geographic regions
(North America, Europe, Asia, and ROW).

The North American region led the market in 2018, followed by Europe,
Asia, and ROW respectively. The presence of the US, the world’s largest
pharmaceutical market, is driving the market growth in the region.
Furthermore, the brain tumor therapeutics market is expected to grow
significantly in North America due to the increasing number of awareness
campaigns conducted by various organizations and vendors in the market
to increase awareness about brain cancer indications.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com